Published in Cancer Res on July 28, 2009
Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer Cell (2011) 2.23
Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res (2011) 2.11
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J (2011) 1.72
Breast and prostate cancer: more similar than different. Nat Rev Cancer (2010) 1.48
Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol (2012) 1.44
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures. Breast Cancer Res Treat (2012) 1.31
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res (2014) 1.23
DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation. Cell Death Dis (2013) 1.08
The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation. Breast Cancer Res (2012) 1.07
Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element. Nucleic Acids Res (2010) 1.06
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. Br J Cancer (2012) 1.05
Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified? Am J Cancer Res (2014) 1.03
Progesterone action in breast, uterine, and ovarian cancers. J Mol Endocrinol (2015) 0.98
Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes? Ann Oncol (2012) 0.94
Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells. Nucleic Acids Res (2013) 0.93
Molecular determinants of context-dependent progesterone receptor action in breast cancer. BMC Med (2014) 0.92
Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients. Br J Cancer (2011) 0.92
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines. Breast Cancer Res (2014) 0.92
Estradiol induction of spermatogenesis is mediated via an estrogen receptor-{alpha} mechanism involving neuroendocrine activation of follicle-stimulating hormone secretion. Endocrinology (2010) 0.91
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer. Breast Cancer Res Treat (2014) 0.90
Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells. Mol Endocrinol (2012) 0.89
Targeting the androgen receptor in prostate and breast cancer: several new agents in development. Endocr Relat Cancer (2015) 0.89
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. Cancers (Basel) (2014) 0.88
Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status. Oncotarget (2016) 0.86
The Role of Androgen Receptor in Breast Cancer. Drug Discov Today Dis Mech (2012) 0.86
BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1. Sci Rep (2016) 0.84
Androgens in human breast carcinoma. Med Mol Morphol (2010) 0.84
Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis. J Breast Cancer (2015) 0.83
Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling. BMC Cancer (2014) 0.83
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer. Breast Cancer Res Treat (2015) 0.82
Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer. Br J Cancer (2016) 0.82
Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer. Cancer Med (2013) 0.82
Insulin priming effect on estradiol-induced breast cancer metabolism and growth. Cancer Biol Ther (2015) 0.82
A simple and reproducible prognostic index in luminal ER-positive breast cancers. Ann Oncol (2013) 0.81
Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer. Cancer Sci (2015) 0.80
Expression of androgen receptor and its phosphorylated forms in breast cancer progression. Cancer (2013) 0.80
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer. Oncotarget (2015) 0.80
Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells. J Mammary Gland Biol Neoplasia (2015) 0.80
Androgen Receptor: A Complex Therapeutic Target for Breast Cancer. Cancers (Basel) (2016) 0.79
Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer. Clin Cancer Res (2014) 0.79
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers. J Cancer Res Clin Oncol (2013) 0.79
Cooperative Dynamics of AR and ER Activity in Breast Cancer. Mol Cancer Res (2016) 0.79
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer. Clin Cancer Res (2016) 0.78
Role of the androgen receptor in triple-negative breast cancer. Clin Adv Hematol Oncol (2016) 0.78
Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor. Mol Cell Endocrinol (2014) 0.78
Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms. Oncogene (2016) 0.78
Deciphering the divergent roles of progestogens in breast cancer. Nat Rev Cancer (2016) 0.77
Androgen receptor expression and its relationship with clinicopathological parameters in an Iranian population with invasive breast carcinoma. Adv Biomed Res (2014) 0.77
Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status. Cancer Epidemiol Biomarkers Prev (2015) 0.77
Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis. Oncoimmunology (2015) 0.76
Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed Therapy. Curr Breast Cancer Rep (2014) 0.76
Expression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in Prognostication. Transl Oncol (2014) 0.76
AR Signaling in Breast Cancer. Cancers (Basel) (2017) 0.75
Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer. Breast Cancer Res (2015) 0.75
Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy. Springerplus (2015) 0.75
Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer. Appl Immunohistochem Mol Morphol (2016) 0.75
Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy. Endocrinology (2016) 0.75
A Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese Medicines. PLoS One (2017) 0.75
The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds. Front Genet (2016) 0.75
Androgen Receptor as a Potential Target for Treatment of Breast Cancer. Int J Cancer Res Mol Mech (2016) 0.75
Prohibitin promotes androgen receptor activation in ER-positive breast cancer. Cell Cycle (2017) 0.75
Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer. Oncotarget (2016) 0.75
A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland. Cancers (Basel) (2017) 0.75
Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer. Virchows Arch (2016) 0.75
Dietary lignan intake and androgen receptor expression in breast tumors. Cancer Causes Control (2014) 0.75
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling. Front Endocrinol (Lausanne) (2016) 0.75
AR-Signaling in Human Malignancies: Prostate Cancer and Beyond. Cancers (Basel) (2017) 0.75
Comparing the rules of engagement of androgen and glucocorticoid receptors. Cell Mol Life Sci (2017) 0.75
Cinical Significance of Androgen Receptor, CK-5/6, KI-67 and Molecular Subtypes in Breast Cancer. J Breast Health (2013) (2014) 0.75
The role of androgens in experimental rodent mammary carcinogenesis. Breast Cancer Res (2014) 0.75
Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer. Eur J Endocrinol (2016) 0.75
Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast. Cancer Sci (2014) 0.75
Early versus late distant metastasis and adjuvant chemotherapy alone versus both radiotherapy and chemotherapy in molecular apocrine breast cancer. Oncotarget (2016) 0.75
Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. PLoS One (2013) 0.75
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort. Breast Cancer Res Treat (2017) 0.75
The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer. Horm Cancer (2017) 0.75
Targeting the androgen receptor in triple-negative breast cancer: current perspectives. Onco Targets Ther (2017) 0.75
Androgen receptor expression on circulating tumor cells in metastatic breast cancer. PLoS One (2017) 0.75
C1orf64 is a novel androgen receptor target gene and coregulator that interacts with 14-3-3 protein in breast cancer. Oncotarget (2017) 0.75
Androgen receptor expression: prognostic value in locally advanced squamous cell carcinoma of the head and neck. Strahlenther Onkol (2013) 0.75
Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy - a Prospective Clinical Study. Breast Care (Basel) (2017) 0.75
International network of cancer genome projects. Nature (2010) 20.35
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell (2006) 8.46
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet (2009) 6.99
Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer (2009) 5.89
Cyclin D as a therapeutic target in cancer. Nat Rev Cancer (2011) 5.76
Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer. N Engl J Med (2015) 5.66
Germline competent embryonic stem cells derived from rat blastocysts. Cell (2008) 5.52
Food insufficiency is associated with high-risk sexual behavior among women in Botswana and Swaziland. PLoS Med (2007) 4.48
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet (2011) 3.73
Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet (2009) 3.59
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci U S A (2010) 3.37
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocr Relat Cancer (2004) 3.03
Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev (2005) 2.87
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Proc Natl Acad Sci U S A (2010) 2.67
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol (2002) 2.51
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci U S A (2003) 2.31
Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS One (2007) 2.26
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. J Clin Oncol (2013) 2.26
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol (2009) 2.21
Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity. PLoS One (2008) 2.18
Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat (2003) 2.14
Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer. Nat Commun (2013) 2.11
Variable stoichiometry of the TatA component of the twin-arginine protein transport system observed by in vivo single-molecule imaging. Proc Natl Acad Sci U S A (2008) 2.09
Distinct nuclear receptor expression in stroma adjacent to breast tumors. Breast Cancer Res Treat (2013) 2.05
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol (2003) 1.96
Role of the Escherichia coli Tat pathway in outer membrane integrity. Mol Microbiol (2003) 1.96
The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study. Cancer Epidemiol Biomarkers Prev (2007) 1.95
Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer (2007) 1.94
Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol (2009) 1.94
Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell (2012) 1.91
Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood (2008) 1.90
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int J Cancer (2010) 1.89
Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning services. Cochrane Database Syst Rev (2012) 1.84
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res (2003) 1.81
Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors. Clin Cancer Res (2012) 1.78
DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J Clin Oncol (2002) 1.78
Increasing trends in elderly persons' use of nonvitamin, nonmineral dietary supplements and concurrent use of medications. J Am Diet Assoc (2005) 1.76
Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum Mol Genet (2004) 1.74
Mutation of the androgen receptor causes oncogenic transformation of the prostate. Proc Natl Acad Sci U S A (2005) 1.73
Exploring the patterns of use and the feasibility of using cellular phones for clinic appointment reminders and adherence messages in an antiretroviral treatment clinic, Durban, South Africa. AIDS Patient Care STDS (2010) 1.73
Coordinating assembly and export of complex bacterial proteins. EMBO J (2004) 1.73
Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr Relat Cancer (2005) 1.73
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J (2011) 1.72
FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Res (2012) 1.71
Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development. J Natl Cancer Inst (2013) 1.70
Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol Endocrinol (2007) 1.68
Cell cycle control in breast cancer cells. J Cell Biochem (2006) 1.68
The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron (2011) 1.67
Social cognition and face processing in schizophrenia. Br J Psychiatry (2004) 1.67
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res (2004) 1.65
Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov (2012) 1.63
Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. Cancer Res (2010) 1.62
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. Int J Cancer (2012) 1.60
Curcumin attenuates acrylamide-induced cytotoxicity and genotoxicity in HepG2 cells by ROS scavenging. J Agric Food Chem (2008) 1.57
Outcomes of transperineal template-guided prostate biopsy in 409 patients. BJU Int (2013) 1.55
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors. Cell Cycle (2012) 1.54
EphB4 expression and biological significance in prostate cancer. Cancer Res (2005) 1.53
Molecular markers of prostate cancer outcome. Eur J Cancer (2005) 1.52
An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res (2005) 1.52
A noncoding RNA antisense to moesin at 5p14.1 in autism. Sci Transl Med (2012) 1.51
Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys. J Clin Endocrinol Metab (2011) 1.50
Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Mol Cancer Res (2003) 1.49
Breast and prostate cancer: more similar than different. Nat Rev Cancer (2010) 1.48
Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res (2005) 1.48
Conserved network of proteins essential for bacterial viability. J Bacteriol (2009) 1.48